What is Ginkgo Bioworks's DENMARK — concentration risk?

Ginkgo Bioworks (DNA) reported DENMARK — concentration risk of 13% in Q1 2026.

What does DENMARK — concentration risk mean?

This metric measures the degree of revenue or operational dependency on the Denmark geographic segment relative to the company's total consolidated performance. It assesses the potential impact of localized market volatility, regulatory changes, or client attrition within this specific region on overall business stability. High concentration in a single geography increases exposure to regional economic risks and may necessitate broader diversification strategies to mitigate potential revenue disruption.

Ginkgo Bioworks (DNA) DENMARK — Concentration risk

Screener

Other geography segments

UNITED STATES

83%+5.1%

Similar metrics at other companies

OBDCInternational — Concentration risk

7.1%+0.9pp

OBDCMidwest — Concentration risk

20.5%-1.2pp

OBDCNortheast — Concentration risk

21.7%+3.8pp

OBDCSouth — Concentration risk

36.9%+1.5pp

OBDCWest — Concentration risk

13.8%-5.0pp

LNZAForeign — Concentration risk

79%+10.0pp

Other financials

Income statement

See full

Revenue$20.2M-48.5%

Gross profit$18.4M-45.4%

Operating income-$58.5M-0.7%

Net income-$46.7M+22.5%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$172.0M-31.6%

Total debt$404.1M-5.8%

Total equity$420.3M-31.4%

Total assets$990.0M-19.6%

Cash flow

See full

Operating cash flow-$44.3M-10.0%

CapEx$2.6M+6,792%

Free cash flow-$46.9M-16.4%

Valuation

See full

Market cap$515.15M-26.8%

Enterprise value$747.25M-15.2%

P/S4.6×+1.3×

Profitability

See full

Gross margin91.8%—

Operating margin-259.9%+1,304pp

Net margin-260%+718pp

FCF margin-156.3%+38.7pp

Returns & leverage

See full

Return on equity-56.3%+23.1pp

Debt / equity1×+0.3×

Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.

The source filing: Ginkgo Bioworks’s 10-Q, filed May 7, 2026.

Filed: May 7, 2026, 4:13 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001628280-26-032116

The Company’s total revenue is primarily generated from customers located in the United States. For the three months ended March 31, 2026 and 2025, U.S. customers accounted for 66% and 81%, respectively. For the three months ended March 31, 2026 and 2025, customers from Denmark accounted for 13% and 11%, respectively.

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's DENMARK — concentration risk?: Ginkgo Bioworks (DNA) reported DENMARK — concentration risk of 13% in Q1 2026.
What does DENMARK — concentration risk mean?: This metric measures the degree of revenue or operational dependency on the Denmark geographic segment relative to the company's total consolidated performance. It assesses the potential impact of localized market volatility, regulatory changes, or client attrition within this specific region on overall business stability. High concentration in a single geography increases exposure to regional economic risks and may necessitate broader diversification strategies to mitigate potential revenue disruption.